Yunpeng Pharmaceutical Group is a comprehensive enterprise group integrating medicines R&D, production and sales into one entity. It has seven subsidiary companies and one branch company with a total asset of RMB 1 billion Yuan.Established in 1999 Yunpeng has matured as a manufacturer of API, FDF of generic drugs and traditional Chinese medicines under GMP certification. Available USP /EP/BP/JP/CP multinational standards of Indometacin, Mexiletine Hydrochloride, Carbocystine and Vitamin U are popular as superior quality and attractive pricing. Hundreds of formulation drugs, For example, Nefidipine Sustained release Tablets (II) is well-known in China market.